Last $14.63 USD
Change Today -0.38 / -2.53%
Volume 324.2K
IVC On Other Exchanges
Symbol
Exchange
New York
OTC US
Frankfurt
As of 8:04 PM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

invacare corp (IVC) Snapshot

Open
$14.98
Previous Close
$15.01
Day High
$15.00
Day Low
$14.56
52 Week High
01/22/14 - $25.96
52 Week Low
07/25/14 - $14.46
Market Cap
470.4M
Average Volume 10 Days
367.8K
EPS TTM
$-1.12
Shares Outstanding
31.1M
EX-Date
07/1/14
P/E TM
--
Dividend
$0.05
Dividend Yield
0.34%
Current Stock Chart for INVACARE CORP (IVC)

Related News

No related news articles were found.

invacare corp (IVC) Related Businessweek News

No Related Businessweek News Found

invacare corp (IVC) Details

Invacare Corporation designs, manufactures, and distributes medical equipment and supplies worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and Asia/Pacific. It offers mobility and seating products, including power wheelchairs, custom manual wheelchairs, personal mobility products, and seating and positioning products; lifestyle products, such as manual wheelchairs, personal care products, homecare beds, pressure relieving mattresses, and patient transport products; and respiratory therapy products comprising non-delivery oxygen, non-delivery respiratory products, and stationary oxygen concentrators. It also provides assistance in the collection of rental capabilities, software, and technology to streamline efficiencies, repair services, and replacement parts. In addition, the company manufactures and distributes healthcare furnishings comprising beds, case goods, and patient handling equipment for the long-term care markets; and other home medical equipment and accessory products. Further, it is involved in the rental of home medical equipment. The company sells its products primarily to home health care and medical equipment providers, distributors, and government locations through its sales force, telesales associates, and independent manufacturers’ representatives and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.

5,400 Employees
Last Reported Date: 07/24/14
Founded in 1885

invacare corp (IVC) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $875.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $420.2K
Senior Vice President of Electronic & Design ...
Total Annual Compensation: $435.0K
Compensation as of Fiscal Year 2013.

invacare corp (IVC) Key Developments

Invacare Corporation Announces Changes to the Management Team, Effective July 31, 2014

Invacare Corporation announced that Gerald B. Blouch, President and Chief Executive Officer, will retire effective July 31, 2014. Mr. Blouch also will retire from his position as a member of the Board of Directors at that time. Robert K. Gudbranson, Invacare's Senior Vice President and Chief Financial Officer, has been named interim President and Chief Executive Officer, while retaining his role as the company's Chief Financial Officer. The Board of Directors will be launching a comprehensive executive search process to identify a Chief Executive Officer and will retain a leading executive recruiting firm to assist in the national search. The search will include a full review of both internal and external candidates. Mr. Gudbranson has served as Invacare's Senior Vice President and Chief Financial Officer since 2008. Prior to that, Mr. Gudbranson was Vice President of Strategic Planning and Acquisitions for Lincoln Electric Holdings Inc.

Invacare Corporation Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Invacare Corporation announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, net sales were $331,312,000 against $344,760,000 a year ago. Loss from continuing operations before income taxes was $10,537,000 against $13,864,000 a year ago. Loss from continuing operations was $13,612,000 against $24,489,000 a year ago. Net Loss was $13,612,000 against $12,461,000 a year ago. Net loss per share basic and diluted from continuing operations was $0.43 against $0.77 a year ago. Net loss per share basic and diluted was $0.43 against $0.39 a year ago. LBITDA was $665,000 against $2,996,000 a year ago. Adjusted EBITDA was $4,422,000 against $759,000 a year ago. Adjusted loss before income taxes was $8,272,000 against $11,302,000 a year ago. Adjusted net loss was $11,422,000 or $0.36 per assuming dilution share against $13,552,000 or $0.42 per assuming dilution share a year ago. Net cash used in operating activities was $6,879,000 against net cash provided by operating activities of $29,964,000 a year ago. Purchases of property and equipment, net were $3,270,000 against $3,796,000 a year ago. Negative free cash flow was $8,588,000 against free cash flow of $2,947,000 a year ago. For the six months, net sales were $640,381,000 against $676,197,000 a year ago. Loss from continuing operations before income taxes was $26,288,000 against $27,047,000 a year ago. Loss from continuing operations was $31,588,000 against $30,197,000 a year ago. Net loss was $31,588,000 against net earnings of $22,720,000 a year ago. Net loss per share basic and diluted from continuing operations was $0.99 against $0.95 a year ago. Net loss per share basic and diluted was $0.99 against net earnings per share basic and diluted of $0.71 a year ago. LBITDA was $6,103,000 against $6,232,000 a year ago. Adjusted EBITDA was $3,038,000 against $39,000 a year ago. Adjusted loss before income taxes was $21,613,000 against $21,997,000 a year ago. Adjusted net loss was $27,013,000 or $0.84 per assuming dilution share against $26,487,000 or $0.83 per assuming dilution share a year ago. Net cash used in operating activities was $13,899,000 against $29,964,000 a year ago. Purchases of property and equipment, net were $6,895,000 against $7,657,000 a year ago. Negative free cash flow was $17,327,000 against $33,117,000 a year ago.

Invacare Corporation to Report Q2, 2014 Results on Jul 24, 2014

Invacare Corporation announced that they will report Q2, 2014 results at 9:00 AM, Eastern Standard Time on Jul 24, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IVC:US $14.63 USD -0.38

IVC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hill-Rom Holdings Inc $40.02 USD -0.04
Inogen Inc $19.90 USD +0.59
Span-America Medical Systems Inc $19.67 USD -0.2685
View Industry Companies
 

Industry Analysis

IVC

Industry Average

Valuation IVC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 0.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INVACARE CORP, please visit www.invacare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.